Similar Articles
A retrospective review of antiphospholipid syndrome from a South Asian country
Muhammad Zain Mushtaq, Syed Ahsan Ali, Zaibunnisa Sattar, Saad Bin Zafar Mahmood, Tazein Amber, Mehmood Riaz
DOI: 10.46497/ArchRheumatol.2022.8979
Issue: Volume 37 - Issue 1 - March 2022
1323
1282
Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients
Eman Eissa, Botros Morcos, Dalia Dorgham, Naglaa Kholoussi
DOI: 10.46497/ArchRheumatol.2022.9217
Issue: Volume 37 - Issue 3 - September 2022
1081
969
Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify?
Hejun Li, Yiqing Zheng, Ling Chen, Shunping Lin
DOI: 10.46497/ArchRheumatol.2022.9366
Issue: Volume 37 - Issue 4 - December 2022
2054
1363
The ABCs of antiphospholipid syndrome
Ayşe Bahar Keleşoğlu Dinçer, Doruk Erkan
DOI: 10.46497/ArchRheumatol.2023.41875
Issue: Volume 38 - Issue 2 - June 2023
891
1087
Analysis of treatment outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis on rituximab therapy
Tsvetelina Yoneva, Yana Zdravkova, Georgi Kotov, Ekaterina Ivanova Todorova, Georgi Vasilev, Rasho Rashkov, Ivan Sheytanov
DOI: 10.46497/ArchRheumatol.2023.9556
Issue: Volume 38 - Issue 3 - September 2023
604
552